HERON THERAPEUTICS, INC. /DE/ Interest Payable, Current
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Interest Payable, Current of $904.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-02-26
- 2025-12-31: Interest Payable, Current $904.00K.
- 2024-12-31: Interest Payable, Current $237.00K.
- 2023-12-31: Interest Payable, Current $412.00K.
- 2022-12-31: Interest Payable, Current $94.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2025-12-31 | $904.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $237.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $412.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $94.00K 10-K · filed 2024-03-12 |
| 2013-09-30 | $74.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $73.00K 10-Q · filed 2013-08-08 |
| 2012-09-30 | $70.00K 10-Q · filed 2012-11-05 |
| 2012-06-30 | $51.00K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |